Filing search / Intra-Cellular Therapies, Inc. / "Litigation" / Page 8

8-K

EX-99.1

slm6dzbb0 ceo27

4 Mar 15

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

12:00am

8-K

EX-99.1

2azt2 0es6b030t

12 Aug 14

Company announces successful End-of Phase 2 meeting with the FDA and Phase 3 plans for ITI-007 for schizophrenia

12:00am

424B3

1b6 nwagebc

6 May 14

Prospectus supplement

12:00am

8-K

EX-99.1

yi7z9ip1g4 fum

7 Apr 14

Other Events

12:00am

424B3

d2do6kq7 g02

7 Apr 14

Prospectus supplement

12:00am

424B3

a6gr befzib2jodxo4

4 Apr 14

Prospectus supplement

12:00am

8-K

EX-99.1

cyb4 1jh4c8z3

25 Mar 14

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2013 Financial Results

12:00am

424B3

cawdbf4bcla79f86

4 Mar 14

Prospectus supplement

12:00am

424B1

i00ue3yo15iw vt7al6

31 Jan 14

Prospectus with pricing info

12:00am

8-K

EX-14.1

v5i4h7dee5j7i 1y

7 Jan 14

Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

12:00am

424B3

jvfwozeqo4hst jldd

19 Dec 13

Prospectus supplement

12:00am

8-K

EX-99.1

5hmwj 4uf5xyh5

9 Dec 13

Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia

12:00am

8-K/A

x7g77juhim1cxbq8k

31 Oct 13

Entry into a Material Definitive Agreement

12:00am

8-K/A

EX-10.2

xzhoe

31 Oct 13

Entry into a Material Definitive Agreement

12:00am

8-K/A

EX-10.1.1

pfjw52zr od6jdtg4k9

31 Oct 13

Entry into a Material Definitive Agreement

12:00am